References
Anderson, Keaven M. 2007. “Optimal Spending Functions for
Asymmetric Group Sequential Designs.” Biometrical
Journal 49 (3): 337–45.
Anderson, Keaven M., and Jason B. Clark. 2010. “Fitting Spending
Functions.” Statistics in Medicine 29 (3): 321–27.
Bauer, Peter. 1989. “Multistage Testing with Adaptive
Designs.” Biometrie Und Informatik in Medizin Und
Biologie 20: 130–48.
Bauer, Peter, and F. Kohne. 1994. “Evaluation of Experiments with
Adaptive Interim Analyses.” Biometrics 50 (4): 1029–41.
Center for Drug Evaluation and Research. 2008. “Guidance for
Industry on Diabetes Mellitus-Evaluating Cardiovascular Risk in New
Antidiabetic Therapies to Treat Type 2 Diabetes.” United
States Department of Health and Human Services, Food and Drug
Administration. https://www.federalregister.gov/d/E8-30086.
Chen, Y. H. Joshua, David L. DeMets, and K. K. Gordon Lan. 2004.
“Increasing the Sample Size When the Unblinded Interim Result Is
Promising.” Statistics in Medicine 23: 1023–38.
Cui, Lu, HM James Hung, and Sue-Jane Wang. 1999. “Modifications of
Sample Size in Group Sequential Clinical Trials.”
Biometrics 55 (3): 853–57.
Cytel, Inc. 2007. EAST 5. Cambridge, MA: Cytel, Inc.
Farrington, Conor P, and Godfrey Manning. 1990. “Test Statistics
and Sample Size Formulae for Comparative Binomial Trials with Null
Hypothesis of Non-Zero Risk Difference or Non-Unity Relative
Risk.” Statistics in Medicine 9 (12): 1447–54.
Gao, Ping, James H. Ware, and Cyrus Mehta. 2008. “Sample Size
Re-Estimation for Adaptive Sequential Design in Clinical Trials.”
Journal of Biopharmaceutical Statistics 18: 1184–96.
Gordon, Ian, and Ray Watson. 1985. “The Myth of
Continuity-Corrected Sample Size Formulae.” Biometrics
52 (1): 71–76.
Hwang, Irving K, Weichung J Shih, and John S De Cani. 1990. “Group
Sequential Designs Using a Family of Type 1 Error Probability Spending
Functions.” Statistics in Medicine 9 (12): 1439–45.
Jennison, Christopher, and Bruce W. Turnbull. 2000. Group Sequential
Methods with Applications to Clinical Trials. Boca Raton, FL:
Chapman; Hall/CRC.
———. 2003. “Mid-Course Sample Size Modification in Clinical Trials
Based on the Observed Treatment Effect.” Statistics in
Medicine 22: 971–93.
Kim, Kyungmann, and David L Demets. 1987. “Design and Analysis of
Group Sequential Tests Based on Type I Error Spending Rate
Functions.” Biometrika 74 (1): 149–54.
Lachin, John M., and Mary A. Foulkes. 1986. “Evaluation of Sample
Size and Power for Analyses of Survival with Allowance for Nonuniform
Patient Entry, Losses to Follow-up, Noncompliance, and
Stratification.” Biometrics 42 (3): 507–19.
Lan, K K Gordon, and David L DeMets. 1983. “Discrete Sequential
Boundaries for Clinical Trials.” Biometrika 70 (3):
659–63.
Lehmacher, Walter, and Gernot Wassmer. 1999. “Adaptive Sample Size
Calculations in Group Sequential Trials.” Biometrics 55
(4): 1286–90.
Liu, Qing, and George YH Chi. 2001. “On Sample Size and Inference
for Two-Stage Adaptive Designs.” Biometrics 57 (1):
172–77.
Lokhnygina, Yuliya, and Anastasios A Tsiatis. 2008. “Optimal
Two-Stage Group-Sequential Designs.” Journal of Statistical
Planning and Inference 138 (2): 489–99.
Madsen, Richard W, and Kenneth B Fairbanks. 1983. “P Values for Multistage and
Sequential Tests.” Technometrics 25 (3): 285–93.
Mehta, Cyrus, and Stuart Pocock. 2011. “Adaptive Increase in
Sample Size When Interim Results Are Promising: A Practical Guide with
Examples.” Statistics in Medicine 30: 3267–84.
Miettinen, Ollie, and Markku Nurminen. 1985. “Comparative Analysis
of Two Rates.” Statistics in Medicine 4 (2): 213–26.
Müller, Hans-Helge, and Helmut Schäfer. 2001. “Adaptive Group
Sequential Designs for Clinical Trials: Combining the Advantages of
Adaptive and of Classical Group Sequential Approaches.”
Biometrics 57 (3): 886–91.
O’Brien, Peter C, and Thomas R Fleming. 1979. “A Multiple Testing
Procedure for Clinical Trials.” Biometrika 35 (3):
549–56.
Pampallona, Sandro, and Anastasios A Tsiatis. 1994. “Group
Sequential Trials for One-Sided and Two-Sided Hypothesis Testing with
Provision for Early Stopping in Favor of the Null Hypothesis.”
Journal of Statistical Planning and Inference 42 (1-2): 19–35.
Pocock, Stuart J. 1977. “Group Sequential Methods in the Design
and Analysis of Clinical Trials.” Biometrika 64 (2):
191–99.
Posch, Martin, Peter Bauer, and Werner Brannath. 2003. “Issues in
Designing Flexible Trials.” Statistics in Medicine 22:
953–69.
Proschan, Michael A, and Sally A Hunsberger. 1995. “Designed
Extension of Studies Based on Conditional Power.”
Biometrics 51 (4): 1315–24.
Proschan, Michael A., K K Gordon Lan, and Janet Turk Wittes. 2006.
Statistical Monitoring of Clinical Trials. A Unified Approach.
New York, NY: Springer.
Scharfstein, Daniel O, Anastasios A Tsiatis, and James M Robins. 1997.
“Semiparametric Efficiency and Its Implication on the Design and
Analysis of Group-Sequential Studies.” Journal of the
American Statistical Association 92 (440): 1342–50.
Schmitz, Norbert. 1993. Optimal Sequentially Planned Decision
Procedures. Vol. 79. Lecture Notes in Statistics. New York:
Springer.
Sellke, Thomas, and David Siegmund. 1983. “Sequential Analysis of
the Proportional Hazards Model.” Biometrika 70 (2):
315–26.
Slud, Eric, and LJ Wei. 1982. “Two-Sample Repeated Significance
Tests Based on the Modified Wilcoxon Statistic.”
Journal of the American Statistical Association 77 (380):
862–68.
The CAPTURE Investigators. 1997. “Randomised Placebo-Controlled
Trial of Abciximab Before and During Coronary Intervention in Refractory
Unstable Angina: The CAPTURE Study.” The
Lancet 349 (9063): 1429–35.
The GUSTO V Investigators. 2001. “Reperfusion Therapy for Acute
Myocardial Infarction with Fibrinolytic Therapy or Combination Reduced
Fibrinolytic Therapy and Platelet Glycoprotein
IIb/IIIa Inhibition: The GUSTO V
Randomised Trial.” The Lancet 357 (9272): 1905–14.
Tsiatis, Anastasios A. 1982. “Repeated Significance Testing for a
General Class of Statistics Use in Censored Survival Analysis.”
Journal of the American Statistical Association 77 (380):
855–61.
Wang, Samuel K, and Anastasios A Tsiatis. 1987. “Approximately
Optimal One-Parameter Boundaries for Group Sequential Trials.”
Biometrics 43 (1): 193–99.
Wang, Sue-Jane, H. M. James Hung, and Robert O’Neill. 2012.
“Paradigms for Adaptive Statistical Information Designs: Practical
Experiences and Strategies.” Statistics in Medicine 31:
3011–23.
Wassmer, Gernot. 2006. “Planning and Analyzing Adaptive Group
Sequential Survival Trials.” Biometrical Journal: Journal of
Mathematical Methods in Biosciences 48 (4): 714–29.